Repligen (RGEN) Depreciation & Amortization (CF) (2010 - 2026)
Repligen (RGEN) reported Depreciation & Amortization (CF) of $19.8 million for Q1 2026, up 5.66% year-over-year from $18.7 million in Q1 2025, and down 0.95% quarter-over-quarter from $20.0 million in Q4 2025.
Repligen (RGEN) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Repligen (RGEN) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $19.8 million in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $19.8 million, up 5.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $79.8 million (up 11.66% YoY), and the FY2025 annual result was $78.7 million, up 13.02% from the prior year.
- Depreciation & Amortization (CF) fell to $19.8 million in Q1 2026 per RGEN's latest filing, from $20.0 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $20.1 million in Q2 2025 and troughed at $11.8 million in Q1 2022.
- A 5-year average of $16.9 million and a median of $17.3 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) soared 56.42% in 2023, then dropped 12.11% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $14.4 million in 2022, then climbed by 20.03% to $17.3 million in 2023, then advanced by 6.41% to $18.4 million in 2024, then increased by 8.62% to $20.0 million in 2025, then retreated by 0.95% to $19.8 million in 2026.
- Business Quant data shows RGEN's Depreciation & Amortization (CF) at $19.8 million in Q1 2026, $20.0 million in Q4 2025, and $20.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn | 19.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.76 Mn |
| Mar 31, 2026 | 19.76 Mn |
| Dec 31, 2025 | 19.95 Mn |
| Dec 31, 2025 | 19.95 Mn |
| Sep 30, 2025 | 20.01 Mn |
| Sep 30, 2025 | 20.01 Mn |
| Jun 30, 2025 | 20.08 Mn |
| Jun 30, 2025 | 20.08 Mn |
| Mar 31, 2025 | 18.70 Mn |
| Mar 31, 2025 | 18.70 Mn |
| Dec 31, 2024 | 18.37 Mn |
| Dec 31, 2024 | 18.37 Mn |
| Sep 30, 2024 | 17.42 Mn |
| Sep 30, 2024 | 17.42 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Mar 31, 2024 | 16.91 Mn |
| Mar 31, 2024 | 16.91 Mn |
| Dec 31, 2023 | 17.26 Mn |
| Dec 31, 2023 | 17.26 Mn |